*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D469 - Myelodysplastic syndrome, unspecified - as a primary diagnosis code | D469 - Myelodysplastic syndrome, unspecified - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.2 | |
| Readmission Rate (%) | 31.28 | |
| Unplanned Readmission Rate (%) | 25.81 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 803: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 802: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 201,938 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 7,916 | ||||
| DRG Share of Total Hospitalizations | 0.61 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 61.24 | ||||
| Avg LOS at DRG | 3.4 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 3.56 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 32.67 | ||||
| Unplanned Readmission Rate at DRG | 21.29 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 24.97 | ||||
| Total Medicare payments at DRG | $1,046,791,335 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $45,685,805 | ||||
| Total Medicare payment per Day at DRG | $1,523 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $1,622 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,184 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $5,771 | ||||
| Total Medicare Charges at DRG | $5,572,284,000 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $264,460,910 | ||||
| Avg Charges at DRG | $27,594 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $33,408 | ||||
| Mortality Rate at DRG | 0.31 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 1.14 | ||||
| SNF Discharge Rate at DRG | 12.45 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 17.16 | ||||
| Home Discharge Rate at DRG | 66.72 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 54.9 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 109,018 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 47 | ||||
| DRG Share of Total Hospitalizations | 0.33 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 0.36 | ||||
| Avg LOS at DRG | 12.66 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 12.6 | ||||
| Readmission Rate at DRG | 35.31 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 39.02 | ||||
| Unplanned Readmission Rate at DRG | 20.73 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 29.27 | ||||
| Total Medicare payments at DRG | $3,554,922,428 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $1,608,133 | ||||
| Total Medicare payment per Day at DRG | $2,575 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $2,716 | ||||
| Total Medicare payment per Hospitalization at DRG | $32,609 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $34,216 | ||||
| Total Medicare Charges at DRG | $15,445,232,132 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $8,658,728 | ||||
| Avg Charges at DRG | $141,676 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $184,228 | ||||
| Mortality Rate at DRG | 8.99 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA | ||||
| SNF Discharge Rate at DRG | 27.26 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA | ||||
| Home Discharge Rate at DRG | 27.78 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 25.53 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | |
|---|---|
| Total Hospitalizations at DRG | 48,449 |
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 12 |
| DRG Share of Total Hospitalizations | 0.15 |
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 0.09 |
| Avg LOS at DRG | 29.97 |
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 56.08 |
| Readmission Rate at DRG | 76.3 |
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA |
| Unplanned Readmission Rate at DRG | 6.46 |
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA |
| Total Medicare payments at DRG | $6,190,071,785 |
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $2,134,002 |
| Total Medicare payment per Day at DRG | $4,263 |
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $3,171 |
| Total Medicare payment per Hospitalization at DRG | $127,765 |
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $177,834 |
| Total Medicare Charges at DRG | $28,754,600,069 |
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $15,722,407 |
| Avg Charges at DRG | $593,502 |
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $1,310,201 |
| Mortality Rate at DRG | 20.61 |
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA |
| SNF Discharge Rate at DRG | 12.46 |
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA |
| Home Discharge Rate at DRG | 2.36 |
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 110 |
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 88 |
| BRIGHAM AND WOMEN'S HOSPITAL | 75 FRANCIS ST | BOSTON | MA | 02115 | 42 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. BILLY WAYNE CLOWNEY | 1105 N LAFAYETTE DR | SUMTER | SC | 29150 | 14 |
| Dr. BORIS KHORETS | 2912 AVENUE X | BROOKLYN | NY | 11235 | 12 |
| Dr. STEVEN GRUENSTEIN | 12 E 86TH ST | NEW YORK | NY | 10028 | 11 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. BILLY WAYNE CLOWNEY | 1105 N LAFAYETTE DR | SUMTER | SC | 29150 | 19 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 16 |
| Dr. BORIS KHORETS | 2912 AVENUE X | BROOKLYN | NY | 11235 | 13 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 12,691 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 8.97 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 7.08 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 30.84 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 22.66 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $159,927,723 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $1,780 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $12,602 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $921,677,379 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $72,624 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 17.55 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 22.5 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 22.59 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 408,103 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 2,957 | ||||
| DRG Share of Total Hospitalizations | 1.24 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 2.09 | ||||
| Avg LOS at DRG | 3.52 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 3.94 | ||||
| Readmission Rate at DRG | 17.83 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 28.55 | ||||
| Unplanned Readmission Rate at DRG | 13.81 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 23.09 | ||||
| Total Medicare payments at DRG | $2,416,862,532 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $18,833,654 | ||||
| Total Medicare payment per Day at DRG | $1,682 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $1,616 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $6,369 | ||||
| Total Medicare Charges at DRG | $13,267,744,847 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $112,203,444 | ||||
| Avg Charges at DRG | $32,511 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $37,945 | ||||
| Mortality Rate at DRG | 0.72 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 0.81 | ||||
| SNF Discharge Rate at DRG | 14.1 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 14.34 | ||||
| Home Discharge Rate at DRG | 62.97 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 56.68 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 2,052 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 1.45 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 4.31 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 29.93 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 21.87 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $11,935,436 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $1,350 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $5,816 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $71,079,858 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $34,639 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 1.46 | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 24.71 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 39.62 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 190,819 | ||||
| Total Hospitalizations with ICD D469 - Myelodysplastic syndrome, unspecified | 1,673 | ||||
| DRG Share of Total Hospitalizations | 0.58 | ||||
| % of Total ICD D469 - Myelodysplastic syndrome, unspecified in DRG | 1.18 | ||||
| Avg LOS at DRG | 5.63 | ||||
| Avg LOS with ICD D469 - Myelodysplastic syndrome, unspecified | 6.35 | ||||
| Readmission Rate at DRG | 28.97 | ||||
| Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 36.99 | ||||
| Unplanned Readmission Rate at DRG | 22.07 | ||||
| Unplanned Readmission Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 28.92 | ||||
| Total Medicare payments at DRG | $2,165,853,817 | ||||
| Total Medicare payments with ICD D469 - Myelodysplastic syndrome, unspecified | $19,913,482 | ||||
| Total Medicare payment per Day at DRG | $2,015 | ||||
| Total Medicare payment per Day with ICD D469 - Myelodysplastic syndrome, unspecified | $1,875 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,350 | ||||
| Total Medicare payment per Hospitalization with ICD D469 - Myelodysplastic syndrome, unspecified | $11,903 | ||||
| Total Medicare Charges at DRG | $10,686,431,125 | ||||
| Total Medicare Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $110,581,202 | ||||
| Avg Charges at DRG | $56,003 | ||||
| Avg Charges with ICD D469 - Myelodysplastic syndrome, unspecified | $66,098 | ||||
| Mortality Rate at DRG | 5.35 | ||||
| Mortality Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 5.74 | ||||
| SNF Discharge Rate at DRG | 23.91 | ||||
| SNF Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 23.01 | ||||
| Home Discharge Rate at DRG | 39.51 | ||||
| Home Discharge Rate with ICD D469 - Myelodysplastic syndrome, unspecified | 33.59 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 849 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 592 |
| CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | 524 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 67 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 41 |
| Dr. MARK J AULT | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | 34 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 131 |
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 79 |
| Dr. SCOTT PAUL SHISLER | 1100 S VAN DYKE | BAD AXE | MI | 48413 | 69 |